22157.jpg
mRNA Therapeutics Market Report 2024-2030: A Projected $31.3 Billion Opportunity Dominated by Moderna, BioNTech, and CureVac
29 mai 2024 06h59 HE | Research and Markets
Dublin, May 29, 2024 (GLOBE NEWSWIRE) -- The "mRNA Therapeutics Market Size, Share & Trends Analysis, 2024-2030" report has been added to ResearchAndMarkets.com's offering. The global mRNA...
Global RNA Therapeutics Market
RNA Therapeutics Market Research Report 2023: Focus on mRNA Therapeutics, RNA Interference, Antisense Oligonucleotides - Global Forecast to 2028
31 janv. 2024 05h59 HE | Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "RNA Therapeutics Market by Product (Vaccines, Drugs), Type (mRNA Therapeutics, RNA Interference, Antisense Oligonucleotides), Indication (Infectious...
22157.jpg
Global mRNA Therapeutics Market Set to Reach $21 Billion by 2028 Despite Decline, Fueled by Next-Gen Drugs
25 janv. 2024 09h54 HE | Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "mRNA: Therapeutics and Global Markets" report has been added to ResearchAndMarkets.com's offering.The global market for mRNA therapeutics reached $60...
SNS-INSIDER-300X300.jpg
mRNA Therapeutics Market to Reach USD 45.40 Billion by 2030 as a Result of Advances in Technology, Particularly in Gene Editing and Delivery Systems | Research by SNS Insider
30 mars 2023 11h28 HE | SNS Insider pvt ltd
Pune, March 30, 2023 (GLOBE NEWSWIRE) -- The size of mRNA therapeutics market was valued at USD 39.40 billion in 2022 and is projected to reach USD 45.40 billion by 2030, with a compound annual...
sphericalinsightsoptionblue.png
Global mRNA Therapeutics Market Size To Grow USD 38.15 Billion By 2030 | CAGR of 2.2%
23 mars 2023 13h30 HE | SPHERICAL INSIGHTS LLP
New York, United States , March 23, 2023 (GLOBE NEWSWIRE) -- The Global mRNA Therapeutics Market Size to Grow from USD 33.60 Billion in 2021 to USD 38.15 Billion by 2030, at a Compound Annual Growth...
 BioNTech gibt Gründ
BioNTech gibt Gründung eines interdisziplinären mRNA-Exzellenzzentrums für gemeinsame Forschung mit dem Weizmann Institute of Science in Israel bekannt
01 mars 2023 08h00 HE | BioNTech SE
JERUSALEM, Israel, 1. März 2023 – BioNTech SE (Nasdaq: BNTX, „BioNTech“, „das Unternehmen“) gab heute bekannt, dass das Unternehmen eine Absichtserklärung (Memorandum of Understanding) mit dem...
BioNTech Announces E
BioNTech Announces Establishment of Interdisciplinary mRNA Excellence Center to Conduct Research Jointly with Scientists from Weizmann Institute of Science in Israel
01 mars 2023 08h00 HE | BioNTech SE
JERUSALEM, Israel, March 1, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech”, “the Company”) announced that the Company and the Weizmann Institute of Science (“Weizmann Institute”) signed a Memorandum of...
BioNTech stärkt Prod
BioNTech stärkt Produktionsstandort Marburg durch erste unternehmenseigene Plasmid-DNA-Herstellungsstätte
02 févr. 2023 06h45 HE | BioNTech SE
Plasmide sind ein zentrales Ausgangsmaterial für die Herstellung von mRNA- und zellbasierten MedikamentenBioNTech stellt mit unternehmenseigener Plasmid-Herstellungsstätte die Produktion von zentralem...
BioNTech Strengthens
BioNTech Strengthens Manufacturing Capabilities with First In-House Plasmid DNA Manufacturing Facility
02 févr. 2023 06h45 HE | BioNTech SE
Plasmids are an important starting material for the manufacturing of mRNA- and cell-based drugsThe new plasmid manufacturing facility aims to increase BioNTech’s autonomy and flexibility in...
Roots-Analysis-Logo.png
mRNA therapeutics and mRNA vaccines market is anticipated to grow at a steady pace, till 2035, claims Roots Analysis
01 févr. 2023 10h30 HE | Roots Analysis
London, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of the “mRNA Therapeutics and mRNA Vaccines Market, 2022–2035” report to its list of offerings. The mRNA...